Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
China · Delayed Price · Currency is CNY 8.30
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:002898 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 1,461 | 2,397 | 1,693 | 2,459 | 2,138 | 1,839 | |
Market Cap Growth | 3.36% | 41.58% | -31.14% | 14.98% | 16.27% | 11.64% |
Enterprise Value | 1,524 | 2,484 | 1,776 | 2,529 | 2,215 | 1,915 |
Last Close Price | 8.30 | 13.62 | 9.62 | 13.94 | 12.12 | 10.43 |
PE Ratio | - | - | - | 257.90 | - | - |
Forward PE | - | 53.89 | 53.89 | 53.89 | 53.89 | 53.89 |
PS Ratio | 2.36 | 4.62 | 6.42 | 7.92 | 8.09 | 7.44 |
PB Ratio | 3.87 | 6.24 | 3.39 | 4.59 | 4.06 | 3.26 |
P/TBV Ratio | 4.85 | 7.77 | 3.92 | 5.24 | 4.66 | 3.73 |
P/FCF Ratio | - | - | - | 479.45 | - | 461.13 |
P/OCF Ratio | 91.91 | 125.78 | - | 68.86 | 151.40 | 51.87 |
EV/Sales Ratio | 2.46 | 4.79 | 6.74 | 8.14 | 8.38 | 7.75 |
EV/EBITDA Ratio | 119.87 | 351.99 | 187.86 | 54.64 | - | 342.75 |
EV/EBIT Ratio | - | - | - | 188.96 | - | - |
EV/FCF Ratio | -257.07 | - | - | 493.11 | - | 480.25 |
Debt / Equity Ratio | 0.23 | 0.32 | 0.33 | 0.24 | 0.27 | 0.31 |
Debt / EBITDA Ratio | 6.74 | 11.39 | 14.32 | 2.74 | - | 25.42 |
Debt / FCF Ratio | - | - | - | 24.85 | - | 43.39 |
Net Debt / Equity Ratio | 0.15 | 0.17 | 0.23 | 0.07 | 0.14 | 0.11 |
Net Debt / EBITDA Ratio | 6.37 | 8.96 | 12.30 | 0.83 | -7.61 | 10.69 |
Net Debt / FCF Ratio | -9.52 | -14.73 | -1.58 | 7.44 | -7.25 | 14.98 |
Asset Turnover | 0.74 | 0.63 | 0.33 | 0.37 | 0.31 | 0.29 |
Inventory Turnover | 5.68 | 5.29 | 1.93 | 2.24 | 2.19 | 1.50 |
Quick Ratio | 0.43 | 0.59 | 0.60 | 0.70 | 0.61 | 0.87 |
Current Ratio | 0.85 | 0.84 | 0.98 | 1.13 | 0.86 | 1.09 |
Return on Equity (ROE) | -29.06% | -27.59% | -6.40% | 1.80% | -6.85% | -4.06% |
Return on Assets (ROA) | -3.41% | -3.25% | -1.75% | 1.01% | -3.06% | -1.92% |
Return on Invested Capital (ROIC) | -10.27% | -8.04% | -3.82% | 0.97% | -6.95% | -4.08% |
Return on Capital Employed (ROCE) | -10.90% | -10.10% | -4.10% | 2.30% | -7.70% | -4.20% |
Earnings Yield | -8.84% | -5.05% | -1.96% | 0.39% | -1.75% | -1.27% |
FCF Yield | -0.41% | -0.18% | -4.34% | 0.21% | -0.46% | 0.22% |
Dividend Yield | - | - | - | 0.14% | - | - |
Payout Ratio | - | - | - | 58.52% | - | - |
Buyback Yield / Dilution | -0.05% | 0.02% | -0.07% | 0.06% | 0.01% | -0.01% |
Total Shareholder Return | -0.05% | 0.02% | -0.07% | 0.20% | 0.01% | -0.01% |